Global Shift To Reduced-Risk Nicotine Will Expand Market Opportunities

Key Takeaways

• Early multi-category innovation, global expansion, and regulatory compliance position RLX to capture increased demand as consumers shift to nicotine alternatives.
  
• Strategic acquisitions and diversified international growth reduce reliance on China and support stronger, more stable margins and earnings over time.
  
• RLX faces persistent regulatory, competitive, and execution risks that threaten margins, growth, and long-term demand, despite efforts to expand internationally in a challenging market.

Catalysts

Through its subsidiaries, develops, manufactures, and sells e-vapor products in the People's Republic of China and internationally.

• The ongoing global shift from traditional cigarettes to reduced-risk products, such as e-vapor and oral nicotine, is growing the overall nicotine alternatives market; RLX's leadership and early move into multi-category offerings position it to capture expanding consumer demand, supporting strong long-term revenue growth.
  
• Rising international health consciousness and regulatory efforts against smoking are accelerating consumer adoption of smokeless and electronic delivery systems; RLX's international expansion and compliance-focused portfolio are poised to benefit from increased user base and higher penetration, likely driving revenue and earnings growth through new market access.
  
• Increasing formalization and enforcement of e-vapor regulations globally are reducing gray-market competition, enabling compliant players like RLX to gain market share in both domestic and international markets, which should translate to stronger topline growth and more stable margins.
  
• RLX's commitment to product innovation and pivot to cartridge-based, sustainable technologies aligns with the industry's move away from disposables and towards environmentally preferable alternatives-justifying premium pricing and potentially raising future gross margins.
  
• Expansion into new overseas markets-including recent strategic acquisitions in Europe-provides RLX with diversified revenue streams and new operational capabilities, enhancing growth visibility, lowering reliance on the China market, and supporting increased profitability and earnings stability over time.

RLX Technology Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming RLX Technology's revenue will grow by 25.3% annually over the next 3 years.
• Analysts assume that profit margins will shrink from 24.9% today to 17.2% in 3 years time.
• Analysts expect earnings to reach CN¥985.8 million (and earnings per share of CN¥0.84) by about August 2028, up from CN¥726.8 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting CN¥1.3 billion in earnings, and the most bearish expecting CN¥785.0 million.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 32.2x on those 2028 earnings, up from 28.8x today. This future PE is lower than the current PE for the US Tobacco industry at 34.9x.
• Analysts expect the number of shares outstanding to decline by 0.3% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 7.79%, as per the Simply Wall St company report.

RLX Technology Future Earnings Per Share Growth

Risks

• Over 80-90% of the domestic China market is still dominated by illegal products from small local workshops, which not only creates significant hurdles for RLX to increase its compliant market share, but also risks ongoing revenue suppression and persistent margin pressure due to competition from lower-priced, subpar products that escape regulatory costs.
  
• RLX remains heavily exposed to regulatory risks, as tightening or shifts in global or Chinese e-vapor policies-including potential bans on disposables (for environmental reasons), changes in excise tax regimes, or increasing enforcement-could curtail growth opportunities, increase compliance costs, and compress both revenues and net margins.
  
• Increasing public scrutiny and shifting health trends toward nicotine-free lifestyles or alternative nicotine cessation solutions threaten long-term demand for e-vapor and smokeless nicotine products, potentially leading to stagnation or long-term decline in sales and earnings.
  
• The company's international expansion, while contributing significantly to recent growth, is still nascent and carries significant execution risk-including integration challenges of newly acquired operations, volatile regulatory climates in target countries, and possible dilution of brand focus-which could negatively impact operating margins and sustainable earnings growth.
  
• Intensifying competition from global tobacco majors entering the Asian and European e-vapor space, as well as rapid proliferation of new alternative nicotine technologies (such as oral nicotine and heat-not-burn products), could erode RLX's pricing power and market share, leading to margin pressure and lower future revenue growth.

Valuation

• The analysts have a consensus price target of $2.934 for RLX Technology based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $4.01, and the most bearish reporting a price target of just $2.34.
  
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be CN¥5.7 billion, earnings will come to CN¥985.8 million, and it would be trading on a PE ratio of 32.2x, assuming you use a discount rate of 7.8%.
  
• Given the current share price of $2.4, the analyst price target of $2.93 is 18.2% higher.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.